GE HealthCare Q2 Performance: Beats Expectations, Lifts FY23 Outlook
Portfolio Pulse from Vandana Singh
GE HealthCare Technologies Inc (NASDAQ:GEHC) reported Q2 FY23 sales of $4.82 billion, up 7% Y/Y and 9% on an organic basis, beating the consensus of $4.79 billion. The company posted an adjusted EPS of $0.92, beating the consensus of $0.87. GE HealthCare raised its FY23 organic revenue growth outlook to 6% - 8% Y/Y from a prior range of 5%-7%. The company forecasts adjusted EPS of $3.70-$3.85 compared to previous guidance of $3.60-$3.75 vs. $3.74 consensus. GEHC shares are up 0.74% $81.23 during the premarket session on the last check Tuesday.
July 25, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GE HealthCare reported better than expected Q2 results and raised its FY23 outlook. This positive news has led to a premarket increase in the company's share price.
GE HealthCare's Q2 results exceeded expectations, with sales and adjusted EPS both beating consensus estimates. The company also raised its FY23 outlook, indicating confidence in future performance. These factors are likely to have a positive impact on investor sentiment, leading to an increase in the company's share price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100